Introduction
Aneuploidy has been linked with several conditions deleterious to human health, including 35% of spontaneous abortions, 0.3% of live births with increased chance of birth defects, carcinogenesis and the progression of cancer (1, 2) . Hence, it would be valuable to identify chemicals with a potential aneugenic mechanism in an in vitro screening assay. The mouse lymphoma TK assay (MLA) has been shown to be able to detect a range of genetic events, including point mutations and chromosomal rearrangements (3) . Although the International Conference on Harmonisation S2B guidance states that the MLA is able to detect compounds that induce numerical chromosomal damage and that the detection of aneuploidy inducers is enhanced if the 24-h treatment regimen is used with the microtitre method (4), over the last decade, there has been some debate about whether, or not, the MLA responds to aneugens as a class. Theoretically, if an aneugen induces loss of the copy of chromosome 11b containing the functional tk þ allele, this should be expressed as a trifluorothymidine (TFT)-resistant mutant. Several studies have reported positive results with aneugens including colchicine (5 and Dr Raymond Proudlock, personal communication, Charles Rivers Laboratories), vinblastine (5) carbendazim (6) and taxol (7) . However, with the exception of carbendazim, these positive results have not been easy to reproduce in different laboratories (6) . Furthermore, although a strain of L5178Y cells with only one intact copy of chromosome 11 is known (8) , it has been suggested that L5178Y TK þ/À clone 3.7.2c cells (the cell line used in the MLA) that are monosomic for chromosome 11 are not viable (9, 10) . This would be a pre-requisite if TFT-resistant mutants were to be induced by simple chromosome loss. If aneugens do induce TFT-resistant mutant cells, it is possible that they are the result of more complex mechanisms, for example chromosome loss and subsequent recombination and duplication (11, 12) or simply the induction of chromosome damage since it is known that most aneugens can also induce structural changes to some extent.
'Aneugen' is an umbrella term for compounds that can interact with various components of the cell division apparatus such as microtubules, centrosomes and centromere-associated proteins to give changes in chromosome number. In order to investigate the response of the MLA to aneugens, seven compounds with differing modes of action were tested ( Figure  1 ). To elucidate the mechanism of the responses to carbendazim and taxol, loss of heterozygosity (LOH) at four microsatellite markers on chromosome 11 and chromosome copy number changes was investigated using fluorescent in situ hybridisation (FISH) with chromosome 11 probes. Furthermore, it has previously been observed that the two copies of chromosome 11 have different size centromeres and the larger centromere is the TK competent 11b (24, 25) ; the initial observations were made using G-banding and subsequently confirmed using FISH (7) . Accordingly, centromere size analysis was performed to determine which copies of chromosome 11 were present in TFT-resistant clones following aneugen treatment.
Materials and methods
All chemicals and reagents were purchased from Sigma Aldrich unless otherwise stated.
Test agents
Taxol, carbendazim, noscapine, econazole, chloral hydrate, diazepam, colchicine and 4-nitroquinoline-N-oxide (4-NQO) were dissolved in dimethyl sulphoxide immediately before use.
Cell line and culture conditions
Mouse lymphoma L5178Y TK þ/À cells, clone 3.7.2c, were obtained from Dr J. Cole (MRC Cell Mutation Unit, Brighton, UK) to whom they had been supplied by Dr Don Clive (then at Burroughs Welcome, Research Triangle Park, USA) in 1978. The provenance of the cells is such that it can be demonstrated that the cryopreserved master stock cultures in this laboratory have spent no more than 3 weeks in continuous culture since they were supplied by Dr Don Clive and working cell cultures were cleansed of preexisting TFT-resistant mutants by growth in medium containing methotrexate on only one occasion ( Figure 2 ). All cells were cultured in RPMI 1640 medium (Invitrogen, Paisley, UK) containing 10% heat-inactivated donor horse serum (DHS), 2 mmol/l L-glutamine, 2 mmol/l sodium pyruvate, 1% Pluronic F68, 200 IU/ml penicillin, 200 lg/ml streptomycin and maintained at 37°C in a humidified atmosphere of 5% CO 2 in air. The average doubling time of the L5178Y cells in stationary culture was $9 to 10 h.
The karyotype of the master cultures including modal chromosome number and the copy number of chromosome 11 were determined using the methods described below. Microtitre method to determine mutant frequency at the tk locus (MLA) The MLA was performed essentially as described by Clements (28) with treatment for 24 h in the absence of an exogenous metabolising system. This exposure condition is considered to be the most suitable to identify divisiondependent mutagens and aneugens (29) . For each treatment, 4 Â 10 6 cells were suspended in 20 ml RPMI containing 10% DHS and the test agent, solvent and positive control solutions were added at 1% v/v. Cultures were prepared for controls and each test agent concentration as identified in the  Tables II-IV. 4-NQO was used as the positive control. Following treatment, the cells were centrifuged, washed once and resuspended in 20 ml RPMI medium containing 10% DHS, counted and adjusted to 2 Â 10 5 cells/ml. Cultures were maintained at between $1.5 Â 10 5 and 1 Â 10 6 cells/ml for 2 days and then selected to determine cell viability and resistance to TFT. To determine viability, cultures were plated into two 96-well plates at $1.6 cells per well in RPMI medium containing 20% DHS. To determine TFT resistance, cultures were plated into two 96-well plates at $2000 cells per well in RPMI medium containing 20% DHS and 3 lg/ml TFT. Plates were incubated for up to 14 days, prior to scoring; for TFT-resistant colonies, mutant clones were designated as large (covering approximately one quarter or more of the area of the well) or small (covering less than one quarter of the area of the well). Viability and mutant frequency were calculated using standard methods (28) .
A positive result was determined using the global evaluation factor, i.e. for any concentration, an increase in mutant frequency above concurrent solvent control of !126 Â 10 À6 was considered significant. Toxicity was measured by reduction in relative total growth (RTG), which is the product of suspension growth and Day 2 cloning efficiency. This is the recommended method for toxicity assessment in the MLA (28) . Increases in mutant frequency seen at ,10% RTG were not considered to be biologically significant (30) .
In order to investigate the possible genetic changes resulting in TFTresistant clones, clones were isolated after treatment with two of the aneugens that gave the largest increases in mutant frequency. For carbendazim (Test 3) and taxol (Test 4), an additional four TFT plates for each control and test compound concentration were prepared. Where possible, $7 and 14 days after plating at least 10 large and 10 small mutant clones, respectively, for each concentration were picked and grown in RPMI medium containing 10% DHS for 7-14 days for subsequent LOH and FISH analysis of chromosome 11.
Analysis for LOH Genomic DNA was extracted from TFT-resistant clones using the QiaAmp DNA mini kit according to the manufactures protocol (Qiagen, Crawley, UK). Primer sequences for the polymerase chain reaction (PCR) analysis of LOH on chromosome 11 at microsatellites D11Agl1 (Tk), D11Mit29, D11Mit42 and D11Mit74 (Table I) were taken from Singh et al. (31) and confirmed for Mus musculus using the National Centre for Biotechnology Information (NCBI) primer Basic Local Alignment Search Tool (BLAST) database (32) . These markers were at a location close to the centromere and both proximal and distal to the tk gene. Each amplification reaction contained 10 pmol of each forward and reverse primer (Eurogentech, Southampton, UK), 50 ng DNA and 45 ll of 1.1Â PlatinumÒ Blue PCR supermix (Invitrogen) in a final reaction volume of 50 ll. For D11Agl1 and D11Mit74 loci, amplification reactions were carried out in multiplex reactions. Reactions were performed in a DNA Engine DyadÒ Peltier Thermal Cycler (MJ Research). Cycling conditions consisted of an initial incubation at 95°C for 2 min, followed by nine cycles of 90°C for 45 sec and 60°C for 45 sec, with a decrease in temperature by 1°C per cycle, followed by 24 cycles of 90°C denaturation for 45 sec, 50°C annealing for 45 sec and 72°C extension for 45 sec, with a final extension at 72°C for 10 min. Reaction products (20 ll in almost all cases) were resolved by electrophoresis on a 2% agarose gel, supplemented with 0.6 mg/ml ethidium bromide (Thermo Scientific). Control genomic DNA was used as a positive control for each run using the same conditions. Initial reactions were performed to confirm LOH at D11Agl1(tk) and D11Mit74 loci (the tk locus and the extremes of the investigated span of chromosome 11), followed by further reactions at internal chromosome 11 loci, D11Mit29 and D11Mit42.
Cytogenetic analysis
Analysis of karyotype. Metaphases were prepared by adding colcemid (10 lg/ ml) for 30 mins to cultures containing 5 Â 10 5 cells/ml. The cells were harvested by suspending in 0.56% potassium chloride at 37°C for 12 min and then resuspending in 3:1 methanol/acetic acid three times for 5 min and each then dropped onto clean slides.
Whole chromosome paints (Cambio) were applied to slides and hybridisiation was performed using the HYBriteä in situ hybridisation machine at 72°C for 5 min followed by 37°C for 16-20 h. Following hybridisation, slides were washed in 0.4Â saline-sodium citrate (SSC) containing 0.1% triton X at 72°C and then removed into 2Â SSC wash solution at room temperature. 
Locus positions on chromosome 11 in centimorgans.
Aneugens in the MLA
Following addition of VectaShield anti-fade mountant containing 4#,6-diamidine-2#-phenylindole dihyrdrochloride (DAPI) (Vector Laboratories), cells were visualised using a fluorescent microscope. Where possible, 100 metaphase cells were analysed per slide.
Analysis of L5178Y TFT-resistant mutant clones
Method to determine chromosome 11 copy number. Slides were prepared by cytocentrifugation of 200 ll containing 5 Â 10 5 cells for 8 min at 800 revolutions/min using a Shandon Cytospinä. Slides were air-dried and fixed in 100% methanol; three replicate slides were prepared for each mutant clone. Whole chromosome paint for chromosome 11 fluorescein isothiocyanate (FITC)-labelled (Cambio UK) and a Cy3ä-labelled pancentromeric probe (Cambio UK) were added to each slide. Slides were aged for at least 48 h before 10 ll of the probe mix was applied. Cohybridisation of the probes was performed using the HYBriteä in situ hybridisation machine at 69°C for 5 min followed by 42°C for 16 h. Following hybridisation, slides were washed in 0.4Â SSC containing 0.1% triton X at 72°C and then removed into 2Â SSC wash solution at room temperature. Following addition of VectaShield antifade mountant containing DAPI, cells were visualised using a fluorescent microscope. Where possible, chromosome 11 copy number was scored until $50 cells with the same copy number were recorded per slide.
Identification of chromosomes 11a and 11b
Nine clones (five large and four small) showing LOH at all four markers were harvested for metaphase preparations in order to determine the origin of the copies of chromosome 11. FISH was applied, as above, to the centromeres of all chromosomes with a Cy3ä or FITC-labelled pancentromeric probe and the individual copies of chromosome 11 identified by a FITC or Cy3ä-labelled whole chromosome paint. In each of the nine clones, 20 metaphase preparations were scored and all images captured for peer review.
Results

L5178Y karyotypes
A modal chromosome number of 40 and a composite karyotype 40 X0 der 5t(5;15), der 9t(9;6) Robertsonian fusion 12 and 13, þ15(t15;5), þ15(t15;18), À15q, der 18t(18;6) was established by FISH ( Figure 3) ; this result is the same as the published karyotype by SKY Ò -FISH (33) .
MLA result
Significant increases in mutant frequency (!126 Â 10 À6 above concurrent control) were seen with taxol, carbendazim, econazole and chloral hydrate (Tables II-IV) but only at highly toxic concentrations ( 17% RTG). Only taxol and carbendazim, at single concentrations in one of four and one of three tests, respectively, induced significant increases in mutant frequency at concentrations giving !10% RTG. In the single tests performed with econazole and chloral hydrate, increases in mutant frequency were only seen at concentrations giving 7 and 2% RTG, respectively, i.e. concentrations below the acceptable level of toxicity for analysis in the MLA (30) . Also, where there were significant increases in mutant frequency, there was no clear evidence of a preferential increase in either the number of small or the large mutant clones.
None of these results would be considered to be unequivocally positive using the accepted evaluation criteria for the MLA. However, given the small but reproducible concentration-related increases in mutant frequency, taxol and carbendazim were considered to be weakly positive. Consequently, a further experiment was performed with each in order to investigate chromosome 11 copy number, using FISH, and LOH to examine the possible mechanisms responsible for the small increases in mutant frequency.
No significant increase in mutant frequency was seen following exposure to noscapine, diazepam or colchicine, when tested up to concentrations determined by toxicity (Table II) .
In all tests where it was used, the positive control 4-NQO induced a highly significant increase in mutant frequency.
LOH analysis
The mutation assays with taxol and carbendazim and the results of PCR analysis for LOH of chromosome 11 of clones from them are shown in Tables III and IV and examples of the PCR products from carbendazim-treated clones are shown in Figure  4 . As would be expected from an assay investigating mutation in the tk gene, LOH was often observed at the D11Agl1 (tk) microsatellite marker, independent of LOH at D11Mit74. However, for all clones that demonstrated LOH at tk and D11Mit74, LOH was also seen at D11Mit29 and D11Mit42, regardless of treatment. The vast majority of small clones (95% in taxol Test 4 and 91% in carbendazim Test 3) but fewer large ).
Aneugens in the MLA
clones (77% taxol test and 57% carbendazim test) demonstrated LOH at tk. This is in agreement with previous observations (9, 34, 35) , where LOH at marker tk was reported to be more common in small than large mutant clones, indicating a probable intergenic deletion on chromosome 11.
A concentration-dependent increase in LOH at all markers was seen for both taxol and carbendazim clones, with the highest concentration of both aneugens giving 95% of small clones and 100% of large clones with LOH at all markers. This increase in LOH was not always related to a significant increase in mutant frequency. In contrast, the incidence of LOH at all markers in the concurrent control cultures was 22 or 50% for small clones and 47 or 25% for large clones in taxol and carbendazim tests, respectively. Furthermore, with 4-NQO, LOH at all markers was only seen in $10% to 30% of all clones from both tests.
FISH analysis
The results of the FISH analysis of taxol and carbendazim clones are shown in Tables III and IV, data and images of representative cells are shown in Figures 5 and 6 . Nearly, all clones, 5 of 5 controls and 27 of 31 aneugen-treated, contained a majority of cells with two copies of chromosome 11 and the remaining 4 clones contained cells with a majority of three or more copies. The trisomic clones (all induced by carbendazim) were large and also had multiple translocations of chromosome 11 material. However, the increase in copy number was not concentration related. No clone was seen with a majority single copy of chromosome 11. The majority of diploid clones did contain a small proportion (,25%) of cells with one or ! three copies of chromosome 11. No more than 5% of monosomic cells were seen in any clone and there was no indication of a relationship between this incidence and aneugen concentration.
Nine clones (five large and four small) isolated after taxol treatment showing LOH at all four markers were examined to determine the size of the chromosome 11 centromeres (Table V with representative images in Figure 7) . In all clones examined, the majority of cells contained two copies of chromosome 11 with different sized centromeres. This was consistent with the published karyotype for L5178Y cells containing chromosomes 11a and 11b ( Figure 3H) but is not what would be expected for clones showing apparent complete LOH.
Discussion
The original objective of this study was to determine whether or not the MLA is able to detect aneugens, although it is (18) 4 (18) 11 (15) 7 (15) recognised that these are not a single class but rather a diverse set of chemicals that can interact with various components of the cell division apparatus. It seems clear that the MLA does not respond to all aneugens since no evidence of increased mutant frequency was seen following exposure to noscapine, diazepam or colchicine, even when tested up to concentrations reducing survival as measured by RTG to ,10%. Although some evidence of mutagenicity was seen with taxol, carbendazim, econazole and chloral hydrate, the increases were generally at levels of survival ,10% and it is likely that, if tested as unknown compounds, the majority of these results would not be considered positive using currently accepted mouse lymphoma assay evaluation criteria.
It should be noted that the results obtained with taxol, colchicine and chloral hydrate do not agree with the positive responses previously reported for these compounds (5, 7, 36 ). In the current study, toxicity above and below 10% survival was seen at the same concentrations of taxol in different experiments and this may account for the apparent disagreement between laboratories, i.e. results were called positive or negative depending on whether the increases were seen just above or below 10% survival. Furthermore, in the laboratory where taxol has been reported to be positive, consistent results were not obtained between experiments using different lots of test material (Dr Martha Moore, Division of Genetic and Molecular Toxicology, Federal Drug Administration, personal communication). For colchicine, concentration-related increases in mutant frequency from 0.01 to 0.1 lmol/l have been reported (5) but, again, these were most apparent at concentrations giving ,20% survival. However, it is possible that the karyotype of cells used may also have influenced the response; the cells reported to give positive results contained a population of 2.7% with three copies of chromosome 11 (5) , but no such cells were seen in 600 metaphases in this laboratory. It is theoretically possible that loss of a single chromosome 11b from a trisomic (11a, 11a and 11b) could give rise to a viable TFT-resistant clone, whereas there are data to indicate that cells monosomic for chromosome 11, which would obviously result from loss of a single chromosome from a disomic, are not viable (9, 10) . Although the increases in mutant frequency with taxol and carbendazim were seen at high levels of toxicity, they did represent increases in real numbers of mutant colonies not simply a calculated increase resulting from reduced cloning efficiency. Therefore, TFT-resistant clones surviving treatment with concentrations of each aneugen were analysed for LOH and chromosome 11 karyotype. All the clones treated with high concentrations of either compound showed LOH at the tk locus, as would be expected for TFT-resistant mutants. FISH analysis showed that the majority of cells in every clone had two or more copies of chromosome 11. Although all the mutant clones did contain a small proportion of cells monosomic for chromosome 11 (,5%), it is unlikely that they were related to the induction of TFT resistance by the aneugens. The clones were analysed after growth for at least 3 weeks after treatment, with much of this time in 96-well plates in medium containing TFT. It is probable that the non-diploid cells represent terminal events occurring with time in culture because the incidence was similar in both control and aneugen-treated clones. Hence, there was no evidence to suggest any TFT-resistant clone arose from monosomy of chromosome 11a.
It was notable that at the highest concentration tested of taxol and carbendazim, 95% of small and 100% of large mutant clones analysed had LOH at all markers, although they had two copies of chromosome 11. It also appears that the LOH was a consequence of treatment with the aneugens because only 35% (18/51) control and 18% (7/40) 4-NQOinduced clones showed LOH at all four markers. Honma et al. found similar differences between the LOH for spontaneous and treatment-induced clones with colchicine and vinblastin (5) . The mechanism by which this occurs has not been elucidated, but this may contribute to the difficulty in identifying responses to anuegens in the MLA. The increased level of LOH following aneugen treatment was consistent with loss of chromosome 11b with concomitant duplication of chromosome 11a, which has been proposed as the most likely mechanism responsible for the induction of TFT-resistant mutants by aneugens in the MLA (5, 7, 11) . If the mutant clones showing LOH at all markers had lost chromosome 11b and duplicated 11a, it would be expected that all would have centromeres of the same size, i.e. the small centromere from 11a. However, the large majority (93/120) of taxol-treated clones showed both small and large centromeres, and only two had the expected two small centromeres. The reasons for this are not known but could represent complex chromosome rearrangements such as whole-arm translocations.
Since it is clear that all aneugens are not readily detected in the MLA, it is relevant to consider possible alternative tests. The in vitro micronucleus assay (MN(vit)) is accepted in regulatory guidance as being able to detect aneugens (37) and previous work in this laboratory confirmed colchicine induces micronuclei in L5178Y cells. However, it was necessary to test up to highly toxic concentrations ($50% survival as measured by Relative Increase in Cell Counts or Relative Population Doublings) before a positive response was seen (38) and data from other laboratories confirm this requirement for colchicine, diethylstilboestrol and vinblastin (39, 40) . Hence, while the MN(vit) is capable of detecting aneugenic compounds, testing up to levels of toxicity bordering on the unacceptable may be a pre-requisite for some of them.
In conclusion, some aneugens such as taxol and carbendazim appear to be able to induce real increases in numbers of TFTresistant mutants in mouse lymphoma L5178Y cells but only at highly toxic concentrations ( 17% RTG). Furthermore, these mutants appear to have undergone complex genetic changes Aneugens in the MLA that are not apparent in TK-deficient clones arising spontaneously or after treatment with 4-NQO. However, when considered together, these data show that the MLA cannot be used routinely as a screen to detect aneugens.
